Skip to content

Category Archives: Evalve

Evalve > CE Mark Approval > World’s First Percutaneous Valve Repair System > Functional MR > Ischemic and cardiomyopathy > MitraClip > Non-surgical option > For patients suffering from the effects of mitral regurgitation MR > Endovascular Valve Edge-to-Edge REpair STudy EVEREST > 300 patients treated with approximately 400 MitraClip devices implanted

Wednesday, March 26, 2008

What proress was reported and what milestones achieved in the EVEREST trial? Is Evalve moving toward commercialization in Europe and the U.S.? Does the MitraClip system have the potential to benefit patients who currently suffer from the serious effects of MR? Does the MitraClip offer a new alternative for patients who choose not to undergo […]

Filed in MitraClip, Non-surgical option, For patients suffering from the effects of mitral regur, Endovascular Valve, Ischemic and cardiomyopathy, Functional MR, Evalve, CE Mark Approval, Percutaneous Valve Repair System, Ideas For Surgery News | Comments (0)

Evalve Completes $60 Million Series D Financing > MitraClip Device > Percutaneous repair of cardiac valves > Device for Percutaneous Repair of Mitral Valve Regurgitation > EVEREST Pivotal Study

Thursday, November 29, 2007

Are serial entrepreneurs and VC’s focused on investing even more into Evalve for finally taking the company through the process of innovation to a point of actual value creation? Is Evalve Inc.’s new round of financing a true indication for the high expectations of its investors? Is the participation of Emergent Medical Ventures, the new […]

Filed in Percutaneous Repair of Mitral Valve Regurgitation, Percutaneous repair of cardiac valves, EVEREST Pivotal Study, Entrepreneurs and investors, Allan May, Thomas Fogarty, MitraClip Device, Venture Capital Financing, Minimally invasive approach, Minimally invasive surgery techniques, Cardiovascular devices, Percutaneous approach, Evalve, Minimally Invasive Surgery MIS | Comments (0)